Vitamin A Liver Reserves and Serum Markers of Vitamin A in US Adults at Time of Death
1 other identifier
observational
27
1 country
1
Brief Summary
Minimal human data exist on actual liver vitamin A compared with blood biomarkers. One blood biomarker, the percent of total serum retinol (vitamin A) in the form of retinyl esters, has been suggested to diagnose hypervitaminosis A with cutoffs of 5% and 10%. In this study, investigators aim to compare total liver vitamin A reserves with the percent total serum retinol as retinyl esters to evaluate hypervitaminosis A using autopsy samples from US adults. Investigators also evaluate the sensitivity (the ability of the biomarker to correctly identify those with deficiency) and specificity (the ability of the biomarker to correctly identify those without deficiency) of serum retinol to determine vitamin A deficiency, variation of liver vitamin A concentration among lobes, and liver alpha retinyl ester concentrations, a cleavage product of alpha-carotene, a vitamin A precursor. To conduct the study, matched serum and liver samples were procured from 27 US adult cadavers (from donors age 49-101 years) and their vitamin A biomarkers were analyzed.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for all trials
Started Feb 2012
Longer than P75 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
February 1, 2012
CompletedPrimary Completion
Last participant's last visit for primary outcome
January 31, 2017
CompletedStudy Completion
Last participant's last visit for all outcomes
January 31, 2017
CompletedFirst Submitted
Initial submission to the registry
September 29, 2017
CompletedFirst Posted
Study publicly available on registry
October 9, 2017
CompletedOctober 17, 2017
October 1, 2017
5 years
September 29, 2017
October 13, 2017
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
Serum retinyl esters, nmol/L
Concentration of retinyl esters in subjects' serum
Enrollment
Liver vitamin A reserves, µmol/g
Concentration of vitamin A in subjects' liver samples
Enrollment
Secondary Outcomes (2)
Serum retinol, µmol/L
Enrollment
Liver alpha-retinyl ester, nmol/g
Enrollment
Study Arms (3)
21-54 y
Ages 21-54 y
55-74 y
Ages 55-74 y
>75 y
Age \>75 y
Eligibility Criteria
US adult cadavers from the the National Disease Research Interchange service age 21 years and older, death from any cause.
You may qualify if:
- Human liver and serum samples were acquired as a consecutive sample through a request to the National Disease Research Interchange service, based on sex and age range targets (5 male and 5 female per age group; age groups: 21-54 ; 55-74; 75 and above).
You may not qualify if:
- None
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
University of Wisconsin - Madison
Madison, Wisconsin, 53706, United States
Related Publications (1)
Olsen K, Suri DJ, Davis C, Sheftel J, Nishimoto K, Yamaoka Y, Toya Y, Welham NV, Tanumihardjo SA. Serum retinyl esters are positively correlated with analyzed total liver vitamin A reserves collected from US adults at time of death. Am J Clin Nutr. 2018 Nov 1;108(5):997-1005. doi: 10.1093/ajcn/nqy190.
PMID: 30475970DERIVED
Biospecimen
Serum and liver samples
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- observational
- Observational Model
- OTHER
- Time Perspective
- CROSS SECTIONAL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
September 29, 2017
First Posted
October 9, 2017
Study Start
February 1, 2012
Primary Completion
January 31, 2017
Study Completion
January 31, 2017
Last Updated
October 17, 2017
Record last verified: 2017-10
Data Sharing
- IPD Sharing
- Will not share